WFA
CNMD icon

Wipfli Financial Advisors’s CONMED CNMD Stock Holding History

Wipfli Financial Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$15K Buy
+183
New +$17.3K ﹤0.01% 1681

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wipfli Financial Advisors's CNMD Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in CONMED (CNMD) in Q3 2022: 183 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #1681 among its holdings.

252 funds tracked by Wall St. Rank hold CNMD as of Q3 2022.

  • Wipfli Financial Advisors held 183 shares of CONMED worth $15K as of Q3 2022.
  • CONMED was a new Wipfli Financial Advisors position in Q3 2022.
  • CONMED made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #1681 holding.
  • 252 funds tracked by Wall St. Rank held CONMED as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.